Actively Recruiting
Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer
Led by Instituto Nacional de Cancerologia de Mexico · Updated on 2025-12-23
281
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this non experimental, transversal instrument study is to Construct and determine the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer in Mexican patients with a lung cancer diagnosis. The main question it aims to answer is: What is the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer of the patients with this diagnosis that are currently undergoing an assessment or follow up program of Respiratory Rehabilitation? The Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer (STA-RR-LC) will be psychometrically valid and reliable for the evaluation of therapeutic adherence on patients with lung cancer that are undergoing an assessment or follow up of Respiratory Rehabilitation.Participants will be asked to fill out an Identification card and fill out the fifty-six items presented on the STA-RR-LC.
CONDITIONS
Official Title
Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with lung cancer (SCLC and NSCLC).
- Age 18 years or older.
- Voluntary participation with understanding and acceptance of informed consent.
- Undergoing respiratory rehabilitation treatment with at least one month of assessment and follow-up.
- Currently receiving active medical treatment.
- Any clinical stage of lung cancer.
- Karnofsky Index of 70 or higher.
You will not qualify if you...
- Severe hearing or vision problems that prevent understanding instructions or answering questionnaires.
- Severe psychiatric conditions such as schizophrenia or psychotic disorders.
- Addiction to any psychoactive substances.
- Attention or memory problems that prevent understanding instructions or answering questionnaires.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Instituto Nacional de Cancerologia
Mexico City, Mexico City, Mexico, 14080
Actively Recruiting
Research Team
O
Oscar G Arrieta, MD
CONTACT
J
Josue R Alcantar-Correa, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here